Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors-Reference-Cited by-同舟云学术

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors

Published:2017-12 Issue:23 Volume:5 Page:
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiol Rep

Author:

Ronn Jonas¹,Jensen Elisa P.¹²,Wewer Albrechtsen Nicolai J.¹²,Holst Jens Juul¹²,Sorensen Charlotte M.¹^ORCID

Affiliation:

1. Department of Biomedical Sciences Faculty of Health Sciences University of Copenhagen Copenhagen Denmark

2. NNF Center for Basic Metabolic Research Faculty of Health Sciences University of Copenhagen Copenhagen Denmark

Funder

Danmarks Grundforskningsfond

Hjerteforeningen

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.14814/phy2.13503

Reference57 articles.

1. Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats

2. The impact of insulin resistance on the kidney and vasculature

3. Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men

4. Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

5. Effects of centrally or systemically injected glucagon-like peptide-1 (7–36) amide on release of neurohypophysial hormones and blood pressure in the rat

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism;Pituitary;2024-09-06

2. Exenatide administration time determines the effects on blood pressure dipping indb/dbmice via modulation of food intake and sympathetic activity;2024-07-04

3. Incretin and glucagon receptor polypharmacology in chronic kidney disease;American Journal of Physiology-Endocrinology and Metabolism;2024-06-01

4. Combination therapy for kidney disease in people with diabetes mellitus;Nature Reviews Nephrology;2024-04-03

5. Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease;Biomedicines;2024-03-14